Healthcare Wrap Week 17: Funding Wins, Trial Steps and Plenty of Selling Into Good News

• Patrys led the board after raising cash for its injectable quetiapine trial.
• Firebrick Pharma and 4DMedical fell hard despite positive business updates.
• Revenue growth remained strong in parts of the sector, especially at Bioxyne, Lumos and Vitura.
• Drug developers won key support from regulators, but most are still some distance from sales.